Incyte to pay $12.6 million to settle claims it provided kickbacks through charity
Incyte, a Wilmington pharmaceutical company, has agreed to pay $12.6 million to settle allegations it used an independent foundation to induce Medicare and Tricare patients to purchase the company's drugs.
The Department of Justice alleged that from November 2011 through December 2014, Incyte used the nonprofit as a conduit to pay the copays for patients taking Jakafi, a drug approved in 2011 to treat myleofibrosis that has fueled the company's growth over the past decade.
In a statement, Incyte denied any wrongdoing and said the settlement is not an admission of liability.
"This resolution simply reflects Incyte's desire to put this matter behind it and to continue to prioritize the health and wellbeing of individuals with serious life-threatening conditions," the statement reads.
Read more: https://www.delawareonline.com/story/money/business/2021/05/05/incyte-pay-12-6-million-settle-allegations-operated-kickback-scheme/4960774001/
